Investigating the role of glutathione in mismatch negativity: An insight into NMDA receptor disturbances in bipolar disorder

Clinical Neurophysiology

Volumn 126, Issue 6, 2015, Pages 1178-1184

  Chitty, Kate M ^a   Lagopoulos, Jim ^a   Hickie, Ian B ^a   Hermens, Daniel F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bipolar disorder; Glutathione; Hippocampus; Mismatch negativity; N methyl d aspartate (NMDA) receptor; Proton magnetic resonance spectroscopy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; GLUTATHIONE; LITHIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ALGORITHM; ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION ANXIETY STRESS SCALE; DSM-IV; ELECTROENCEPHALOGRAM; FEMALE; HAMILTON DEPRESSION RATING SCALE; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; MALE; MISMATCH NEGATIVITY; NEUROIMAGING; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; SELF REPORT; SIGNAL NOISE RATIO; STRUCTURED INTERVIEW; YOUNG MANIA RATING SCALE; ADOLESCENT; ELECTROENCEPHALOGRAPHY; METABOLISM; PHYSIOLOGY; PROBLEM SOLVING; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; ELECTROENCEPHALOGRAPHY; FEMALE; GLUTATHIONE; HIPPOCAMPUS; HUMANS; MALE; PROBLEM SOLVING; RECEPTORS, N-METHYL-D-ASPARTATE; YOUNG ADULT;

EID: 84928754046     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2014.09.025     Document Type: Article

References (57)

1. Angst J. The bipolar spectrum. Br J Psychiatry 2007, 190:189-191.
2. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci 2008, 108:227-238.
3. APA Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC.
4. Baldeweg T., Hirsch S.R. Mismatch negativity indexes illness-specific impairments of cortical plasticity in schizophrenia: a comparison with bipolar disorder and Alzheimer's disease. Int J Psychophysiol 2014, [Epub ahead of print]. 10.1016/j.ijpsycho.2014.03.008.
5. Ballesteros A., Summerfelt A., Du X., Jiang P., Chiappelli J., Tagamets M., et al. Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol 2013, 124:2209-2215.
6. Bennett M.R. The concept of long term potentiation of transmission at synapses. Prog Neurobiol 2000, 60:109-137.
7. Cardenas-Rodriguez N., Coballase-Urrutia E., Rivera-Espinosa L., Romero-Toledo A., Sampieri A., Ortega-Cuellar D., et al. Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models. Oxid Med Cell Longev 2013, 2013:598493.
8. Chitty K.M., Lagopoulos J., Lee R.S., Hickie I.B., Hermens D.F. A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder. Eur Neuropsychopharmacol 2013, 23(11):1348-1363.
9. Cooper A.J., Kristal B.S. Multiple roles of glutathione in the central nervous system. Biol Chem 1997, 378:793-802.
10. de Sousa R.T., Zarate C.A., Zanetti M.V., Costa A.C., Talib L.L., Gattaz W.F., et al. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psychiatr Res 2014, 50:36-41.
11. Duffy S.L., Lagopoulos J., Hickie I.B., Diamond K., Graeber M.B., Lewis S.J., et al. Glutathione relates to neuropsychological functioning in mild cognitive impairment. Alzheimers Dement 2014, 10:67-75.
12. Garrido M.I., Kilner J.M., Stephan K.E., Friston K.J. The mismatch negativity: a review of underlying mechanisms. Clin Neurophysiol 2009, 120:453-463.
13. Giard M.H., Lavikahen J., Reinikainen K., Perrin F., Bertrand O., Pernier J., et al. Separate representation of stimulus frequency, intensity, and duration in auditory sensory memory: an event-related potential and dipole-model analysis. J Cogn Neurosci 1995, 7:133-143.
14. Giard M.H., Perrin F., Pernier J., Bouchet P. Brain generators implicated in the processing of auditory stimulus deviance: a topographic event-related potential study. Psychophysiology 1990, 27:627-640.
15. Godlewska B.R., Yip S.W., Near J., Goodwin G.M., Cowen P.J. Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy. Psychopharmacology 2014, 231:327-332.
16. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
17. Harms L.R., Michie P.T. Understanding the pathological mechanisms underpinning functional impairments in schizophrenia: gamma oscillations versus mismatch negativity (MMN) as mediating factors. Clin Neurophysiol 2013, 124:2075-2076.
18. Hermens D.F., Lagopoulos J., Naismith S.L., Tobias-Webb J., Hickie I.B. Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders. Transl Psychiatry 2012, 2:e110.
19. Hermens D.F., Ward P.B., Hodge M.A., Kaur M., Naismith S.L., Hickie I.B. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:822-829.
20. Janaky R., Varga V., Hermann A., Saransaari P., Oja S.S. Mechanisms of l-cysteine neurotoxicity. Neurochem Res 2000, 25:1397-1405.
21. Janaky R., Varga V., Saransaari P., Oja S.S. Glutathione modulates the N-methyl-d-aspartate receptor-activated calcium influx into cultured rat cerebellar granule cells. Neurosci Lett 1993, 156:153-157.
22. Javitt D.C., Schoepp D., Kalivas P.W., Volkow N.D., Zarate C., Merchant K., et al. Translating glutamate: from pathophysiology to treatment. Sci Transl Med 2011, 3:102mr2.
23. Javitt D.C., Schroeder C.E., Steinschneider M., Arezzo J.C., Ritter W., Vaughan H.G. Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. Electroencephalogr Clin Neurophysiol Suppl 1995, 44:161-175.
24. Javitt D.C., Steinschneider M., Schroeder C.E., Arezzo J.C. Role of cortical N-methyl-d-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA 1996, 93:11962-11967.
25. Javitt D.C., Zukin S.R., Heresco-Levy U., Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull 2012, 38:958-966.
26. Jin M.L., Park S.Y., Kim Y.H., Oh J.I., Lee S.J., Park G. The neuroprotective effects of cordycepin inhibit glutamate-induced oxidative and ER stress-associated apoptosis in hippocampal HT22 cells. Neurotoxicology 2014, 41:102-111.
27. Kaur M., Battisti R.A., Lagopoulos J., Ward P.B., Hickie I.B., Hermens D.F. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster. J Psychiatry Neurosci 2012, 37:313-321.
28. Kaur M., Battisti R.A., Ward P.B., Ahmed A., Hickie I.B., Hermens D.F. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups. Schizophr Res 2011, 130:203-209.
29. Kaur M., Lagopoulos J., Ward P.B., Watson T.L., Naismith S.L., Hickie I.B., et al. Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis. PLoS One 2012, 7:e51871.
30. Kenemans J.L., Kahkonen S. How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 2011, 36:26-51.
31. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.L., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002, 32:959-976.
32. Kropotov J.D., Naatnen R., Sevostianov A.V., Alho K., Reinikainen K., Kropotova O.V. Mismatch negativity to auditory stimulus change recorded directly from the human temporal cortex. Psychophysiology 1995, 32:418-422.
33. Lagopoulos J., Hermens D.F., Tobias-Webb J., Duffy S., Naismith S.L., White D., et al. In vivo glutathione levels in young persons with bipolar disorder: a magnetic resonance spectroscopy study. J Psychiatr Res 2013, 47:412-417.
34. Lavoie S., Murray M.M., Deppen P., Knyazeva M.G., Berk M., Boulat O., et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 2008, 33:2187-2199.
35. Leucht S., Kane J.M., Kissling W., Hamann J., Etschel E., Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry 2005, 187:366-371.
36. Lovibond P.F., Lovibond S.H. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 1995, 33:335-343.
37. Naatanen R., Gaillard A.W., Mantysalo S. Early selective-attention effect on evoked potential reinterpreted. Acta psychologica 1978, 42(4):313-329.
38. Naatanen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin Neurophysiol 2007, 118:2544-2590.
39. Ng W.X., Lau I.Y., Graham S., Sim K. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci Biobehav Rev 2009, 33:336-354.
40. Osman A., Wong J.L., Bagge C.L., Freedenthal S., Gutierrez P.M., Lozano G. The Depression Anxiety Stress Scales-21 (DASS-21): further examination of dimensions, scale reliability, and correlates. J Clin Psychol 2012, 68:1322-1338.
41. Overall J., Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep 1962, 10:799-812.
42. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Mag Res Med 1993, 30:672-679.
43. Reinert D.F., Allen J.P. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res 2002, 26:272-279.
44. Rinne T., Alho K., Ilmoniemi R.J., Virtanen J., Naatanen R. Separate time behaviors of the temporal and frontal mismatch negativity sources. Neuroimage 2000, 12:14-19.
45. Ruusuvirta T., Lipponen A., Pellinen E., Penttonen M., Astikainen P. Auditory cortical and hippocampal-system mismatch responses to duration deviants in urethane-anesthetized rats. PLoS One 2013, 8:e54624.
46. Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008, 7:426-437.
47. Scott E.M., Hermens D.F., Glozier N., Naismith S.L., Guastella A.J., Hickie I.B. Targeted primary care-based mental health services for young Australians. Med J Aust 2012, 196:136-140.
48. Semlitsch H.V., Anderer P., Schuster P., Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 1986, 23:695-703.
49. Smith S.M. Fast robust automated brain extraction. Hum Brain Mapp 2002, 17:143-155.
50. Steullet P., Neijt H.C., Cuenod M., Do K.Q. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 2006, 137:807-819.
51. Stone J.M., Bramon E., Pauls A., Sumich A., McGuire P.K. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials. Psychiatry Res 2010, 183:174-176.
52. Sucher N.J., Lipton S.A. Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J Neurosci Res 1991, 30:582-591.
53. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 2005, 76:1-23.
54. Wallin C., Weber S.G., Sandberg M. Glutathione efflux induced by NMDA and kainate: implications in neurotoxicity?. J Neurochem 1999, 73:1566-1572.
55. WHO-ASSIST Working Group The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 2002, 97:1183-1194.
56. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
57. Zimmerman M., Martinez J.H., Young D., Chelminski I., Dalrymple K. Severity classification on the Hamilton Depression Rating Scale. J Affect Disord 2013, 150:384-388.